Chromis Therapeutics
Signal active
Organization
Contact Information
Overview
Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. The company is seeking investment to advance its novel cccDNA inhibitor (CHR101), viral entry and viral capsid assembly inhibitor lead candidates for the treatment of chronic HBV. CHR101 has a potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. CHR101's activity is supported by a robust discovery preclinical data package.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2015
Employees
251-500
Headquarters locations
San Diego, California, United States, North America
Social
Profile Resume
Chromis Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $72.0M in funding across 24 round(s). With a team of 251-500 employees, Chromis Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Chromis Therapeutics, raised $3.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$3.0M
Details
2
Chromis Therapeutics has raised a total of $3.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Seed | |||
| 2016 | Seed | 3.0M |
Investors
Chromis Therapeutics is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Torrey Pines Investment | - | FUNDING ROUND - Torrey Pines Investment | undefined |
| Nikolay Savchuk | - | FUNDING ROUND - Nikolay Savchuk | 3.0M |
| Chromis Therapeutics | - | FUNDING ROUND - Chromis Therapeutics | 3.0M |
| Torrey Pines Investment | - | FUNDING ROUND - Torrey Pines Investment | 3.0M |